Actos Tablet
Product Images NDC 64764-451

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Actos (NDC 64764-451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (352f5dd8 4c3e 4e8e 8167 Bf383bd95dd6 01)

Chemical structure diagram of pioglitazone, the active ingredient in Actos tablets. The diagram shows the molecular structure with various chemical bonds and atoms arranged to represent pioglitazone hydrochloride.*

FDA Label Image

Figure1 (352f5dd8 4c3e 4e8e 8167 Bf383bd95dd6 02)

A line graph showing the mean response over 26 weeks for Placebo, 15 mg, 30 mg, and 45 mg dosages. The x-axis represents time in weeks (0 to 26), and the y-axis represents the mean values ranging from -2.0 to 1.0. Each dosage group is represented by distinct markers and colors, with Placebo showing relatively stable mean values and the 15 mg, 30 mg, and 45 mg doses showing a decreasing trend over time.*

FDA Label Image

Actos 03

Label for Actos 15 mg tablets (pioglitazone) distributed by Takeda Pharmaceuticals America, Inc. The label shows a 30-tablet bottle with storage instructions, a barcode, and a note to dispense with a Medication Guide. It emphasizes not to accept if the bottle seal is broken or missing.*

FDA Label Image

Actos 04

Label for Actos (pioglitazone) 30 mg oral tablets, containing 30 tablets. The label includes storage instructions, dosage reference, and distributor information for Takeda Pharmaceuticals America, Inc. It also provides a NDC number 64764-301-14 and directs users to a medication guide available at www.actos.com.*

FDA Label Image

Actos 05

Label for Actos (pioglitazone) tablets, 45 mg strength, distributed by Takeda Pharmaceuticals America, Inc. The label states each tablet contains pioglitazone hydrochloride equivalent to 45 mg pioglitazone. The package contains 30 tablets. Storage instructions and caution about dispensing in a light-resistant container are included, along with a barcode and the NDC 64764-451-24.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.